Yapeng Mi - Search Results

Year	Number of Results
2013	1
2014	2
2015	5
2016	11
2017	6
2018	1
2019	2
2020	3
2021	4
2022	4
2024	1

1

The nano delivery systems and applications of mRNA.

Li M, Li Y, Li S, Jia L, Wang H, Li M, Deng J, Zhu A, Ma L, Li W, Yu P, Zhu T. Li M, et al. Eur J Med Chem. 2022 Jan 5;227:113910. doi: 10.1016/j.ejmech.2021.113910. Epub 2021 Oct 8. Eur J Med Chem. 2022. PMID: 34689071 Free PMC article. Review.

2

Cyclodextrins based delivery systems for macro biomolecules.

Liu J, Ding X, Fu Y, Xiang C, Yuan Y, Zhang Y, Yu P. Liu J, et al. Eur J Med Chem. 2021 Feb 15;212:113105. doi: 10.1016/j.ejmech.2020.113105. Epub 2020 Dec 16. Eur J Med Chem. 2021. PMID: 33385835 Review.

3

Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems.

Fu Y, Ding Y, Zhang L, Zhang Y, Liu J, Yu P. Fu Y, et al. Eur J Med Chem. 2021 May 5;217:113372. doi: 10.1016/j.ejmech.2021.113372. Epub 2021 Mar 11. Eur J Med Chem. 2021. PMID: 33744689 Free article. Review.

4

Synthesis and immunogenicity of PG-tb1 monovalent glycoconjugate.

Meng X, Ji C, Su C, Shen D, Li Y, Dong P, Yuan D, Yang M, Bai S, Meng D, Fan Z, Yang Y, Yu P, Zhu T. Meng X, et al. Eur J Med Chem. 2017 Jul 7;134:140-146. doi: 10.1016/j.ejmech.2017.03.058. Epub 2017 Mar 27. Eur J Med Chem. 2017. PMID: 28411454

5

Polyvalent effect enhances diglycosidic antiplasmodial activity.

Zhang WQ, He Y, Yu Q, Liu HP, Wang DM, Li XB, Luo J, Meng X, Qin HJ, Lucchi NW, Udhayakumar V, Iyer SS, Yang Y, Yu P. Zhang WQ, et al. Eur J Med Chem. 2016 Oct 4;121:640-648. doi: 10.1016/j.ejmech.2016.05.069. Epub 2016 Jun 2. Eur J Med Chem. 2016. PMID: 27318984

6

Directed evolution engineering to improve activity of glucose dehydrogenase by increasing pocket hydrophobicity.

Hua L, Qianqian B, Jianfeng Z, Yinbiao X, Shengyu Y, Weishi X, Yang S, Yupeng L. Hua L, et al. Front Microbiol. 2022 Nov 9;13:1044226. doi: 10.3389/fmicb.2022.1044226. eCollection 2022. Front Microbiol. 2022. PMID: 36439831 Free PMC article.

7

Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives.

Teng YO, Zhao HY, Wang J, Liu H, Gao ML, Zhou Y, Han KL, Fan ZC, Zhang YM, Sun H, Yu P. Teng YO, et al. Eur J Med Chem. 2016 Apr 13;112:145-156. doi: 10.1016/j.ejmech.2015.12.050. Epub 2016 Feb 6. Eur J Med Chem. 2016. PMID: 26890120

8

Synthesis and immunogenicity of the Mycobacterium tuberculosis arabinomannan-CRM197 conjugate.

Chang Y, Meng X, Li Y, Liang J, Li T, Meng D, Zhu T, Yu P. Chang Y, et al. Medchemcomm. 2019 Apr 2;10(4):543-553. doi: 10.1039/c8md00546j. eCollection 2019 Apr 1. Medchemcomm. 2019. PMID: 31057734 Free PMC article.

9

Synthesis and antioxidant evaluation of desmethylxanthohumol analogs and their dimers.

Teng Y, Li X, Yang K, Li X, Zhang Z, Wang L, Deng Z, Song B, Yan Z, Zhang Y, Lu K, Yu P. Teng Y, et al. Eur J Med Chem. 2017 Jan 5;125:335-345. doi: 10.1016/j.ejmech.2016.09.024. Epub 2016 Sep 13. Eur J Med Chem. 2017. PMID: 27688188

10

The therapeutic inhibition of topoisomerase inhibitor and crizotinib combination in EGFR wild and mutant lung cancer cells.

Liu Z, Li X, Gao J, Yin P, Teng Y, Yu P. Liu Z, et al. Biochem Pharmacol. 2022 Nov;205:115294. doi: 10.1016/j.bcp.2022.115294. Epub 2022 Oct 12. Biochem Pharmacol. 2022. PMID: 36241099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year